Allianz Asset Management Gmb H Reata Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$30.85 - $93.17 $225,205 - $680,141	7,300 New	7,300 $663,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $51,220 - $221,920	-2,000 Reduced 18.13%	9,030 $238,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $23,481 - $45,387	-300 Reduced 2.65%	11,030 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $234,669 - $424,626	2,300 Added 25.47%	11,330 $1.4 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $2.03 Million - $3.55 Million	-21,753 Reduced 70.67%	9,030 $880,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.06 Million - $1.47 Million	8,354 Added 37.25%	30,783 $4.8 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $767,060 - $1.53 Million	6,178 Added 38.02%	22,429 $3.24 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $1.21 Million - $3.54 Million	16,251 New	16,251 $3.32 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.